Driving medical research innovation in Australia

IMCRC congratulates leading global medical technology company Stryker on the opening of its Australian research and development (R&D) lab in Queensland. 

The Lab is established with the support of the Queensland Government, the University of Queensland, Queensland University of Technology and Metro North Hospital and Health Service to accelerate the translation of research within Australia’s medical technology ecosystem. 

Located in Brisbane’s Herston Health Precinct, a collaborative community of health facilities, medical research institutes, universities, and organisations, the R&D Lab will focus on digital, robotics, enabling technology and advanced manufacturing research. 

Stryker’s investment in the R&D Lab stems from its five-year, collaborative research project with IMCRC, RMIT University, St Vincent’s Hospital, University of Technology Sydney, University of Sydney and University of Melbourne. The IMCRC project, which commenced in 2017, combined 3D printing, robotic surgery and advanced manufacturing to create patient-specific bone implants to treat bone cancers and tumors. 

CEO and Managing Director of IMCRC, David Chuter, congratulated Stryker on the opening of its Lab and recognised its ongoing contribution to Australia’s medtech manufacturing ecosystem. 

“As a company at the forefront of medical technology, Stryker’s expanded presence in Australia will generate significant opportunities for researchers, universities and local industry, creating skilled jobs and pathways for collaboration,” he said.